Alirezaylavasani A, Egner IM, Dahl B, Chopra A, de Matos Kasahara T, Goll GL, Jahnsen J, Grødeland G, Vaage JT, Lund-Johansen F, Holter JC, Halvorsen B, Jørgensen KK, Munthe LA, Kared H(2024) Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease Clin Immunol, 271, 110404(in press) DOI 10.1016/j.clim.2024.110404, PubMed 39645159
Scheffer L, Reber EE, Mehta BB, Pavlović M, Chernigovskaya M, Richardson E, Akbar R, Lund-Johansen F, Greiff V, Haff IH, Sandve GK(2024) Predictability of antigen binding based on short motifs in the antibody CDRH3 Brief Bioinform, 25(6) DOI 10.1093/bib/bbae537, PubMed 39438077
Alirezaylavasani A, Skeie LG, Egner IM, Chopra A, Dahl TB, Prebensen C, Vaage JT, Halvorsen B, Lund-Johansen F, Tonby K, Reikvam DH, Stiksrud B, Holter JC, Dyrhol-Riise AM, Munthe LA, Kared H(2024) Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections NPJ Vaccines, 9(1), 185 DOI 10.1038/s41541-024-00972-3, PubMed 39384763
Contact information: Group leader Fridtjof Lund-Johansen, Department of Immunology, Oslo University Hospital, Rikshospitalet, Tel: +47 23073016, E-mail: fridtjof.lund-johansen@rr-research.no